Targeting a condition suffered by nearly a billion people worldwide, a new study has shown a drug previously used to treat depression can reduce obstructive sleep apnea (OSA) severity. While not yet identifying a cure, the authors say the study opens up further avenues for the development of future drug treatments targeted at the huge number of people unable to tolerate current sleep apnea therapies, such as continuous positive airway pressure (CPAP) machines.